This request has
been cleared for 180 days as specified by the em ergency clearance
process. HHS/FDA is required to make changes t o the burden
calculations as discussed as part of OMB review. Ad ditionally,
HHS/FDA has indicated that this is a one-time collect ion, and
therefore OMB assumes that HHS/FDA will submit another p aperwork
request if they want to re-administer the survey.
Inventory as of this Action
Requested
Previously Approved
12/31/2006
12/31/2006
96
0
0
48
0
0
0
0
0
The FDA MedWatch Partners program is
an outreach effort directed at health care provider organizations.
The effort facilitates the timely dissemination of clinically
important new information on drugs, devices and other human medical
care products regulated by the FDA and prescribed, dispensed or
used by the membership of these professional societies. In
voluntarily agreeing to work with FDA MedWatch, these partner
organizations disseminate this information to their members and
their members' patients so medical products necessary to efforts to
improve a patients health may be used more safely and reduce risk
of harm. The....
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.